Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Stephans

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Brachytherapy|January 23, 2016
Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapyYvonne D Pham, Jeffrey A Kittel, Chandana A Reddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2009
Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patientsKevin L Stephans, Toufik Djemil, Chandana A Reddy, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapyBindu V Manyam, Kyle Verdecchia, Kevin Rogacki, et al.
Clinical Genitourinary Cancer|January 10, 2015
Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results databaseMonica E Shukla, Changhong Yu, Chandana A Reddy, et al.
Journal of Applied Clinical Medical Physics|February 17, 2018
Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancerWen Li, Lan Lu, Kevin L Stephans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2019
One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 TrialAnurag K Singh, Jorge A Gomez-Suescun, Kevin L Stephans, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicityKevin L Stephans, Toufik Djemil, Claudiu Diaconu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific MortalityMihir Naik, Chandana A Reddy, Kevin L Stephans, et al.
Practical Radiation Oncology|March 29, 2014
Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patientsGrant K Hunter, Kristin Brockway, Chandana A Reddy, et al.
Cureus|August 27, 2016
A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial FibrillationPing Xia, Rupesh Kotecha, Naveen Sharma, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Brachytherapy|January 23, 2016
Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapyYvonne D Pham, Jeffrey A Kittel, Chandana A Reddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2009
Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patientsKevin L Stephans, Toufik Djemil, Chandana A Reddy, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapyBindu V Manyam, Kyle Verdecchia, Kevin Rogacki, et al.
Clinical Genitourinary Cancer|January 10, 2015
Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results databaseMonica E Shukla, Changhong Yu, Chandana A Reddy, et al.
Journal of Applied Clinical Medical Physics|February 17, 2018
Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancerWen Li, Lan Lu, Kevin L Stephans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2019
One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 TrialAnurag K Singh, Jorge A Gomez-Suescun, Kevin L Stephans, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicityKevin L Stephans, Toufik Djemil, Claudiu Diaconu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific MortalityMihir Naik, Chandana A Reddy, Kevin L Stephans, et al.
Practical Radiation Oncology|March 29, 2014
Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patientsGrant K Hunter, Kristin Brockway, Chandana A Reddy, et al.
Cureus|August 27, 2016
A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial FibrillationPing Xia, Rupesh Kotecha, Naveen Sharma, et al.
Pageof 9